Viewing Study NCT05388760


Ignite Creation Date: 2025-12-25 @ 2:11 AM
Ignite Modification Date: 2025-12-30 @ 9:52 AM
Study NCT ID: NCT05388760
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-11-05
First Post: 2022-05-19
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Tralokinumab Monotherapy for Children With Moderate-to-severe Atopic Dermatitis - TRAPEDS 1 (TRAlokinumab PEDiatric Trial no. 1)
Sponsor: LEO Pharma
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module